RAFAEL HOLDINGS, INC. Foreign Currency Transaction Gain (Loss), Unrealized
RAFAEL HOLDINGS, INC. (RFL) reported Foreign Currency Transaction Gain (Loss), Unrealized of $32.00 thousand for the 12-month period ending 2018-07-31, per its 10-K filed 2019-10-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2019-10-04
- RAFAEL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2018 was $32.00K, a 62.79% decline from fiscal 2017.
- RAFAEL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2017 was $86.00K.
- RAFAEL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2016 was -$13.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|
| 2018-07-31 | $32.00K 10-K · filed 2019-10-04 |
| 2017-07-31 | $86.00K 10-K · filed 2018-10-15 |
| 2016-07-31 | -$13.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |